Article

Analyzing Enhancer Expression In Pan-Cancer Patients

2018-07-31

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

PARP inhibition in cancer therapy

Identifiers and source

Literature Corpus work: 50f8331b-f234-5dec-9672-ba582249261c
DOI: 10.31988/scitrends.24256

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Analyzing Enhancer Expression In Pan-Cancer PatientsDOI 10.31988/scitrends.24256Read

A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient SamplesSemantic proximity Read

The role of enhancers in cancer.Semantic proximity Read

Enhancers: five essential questions.Semantic proximity Read

Chromatin Landscape of Cancer Cell Lines Identifies Enhancer SubtypesSemantic proximity Read

Pan-cancer characterization and clinical outcome of ecDNA-enhancer mediated transcriptional dysregulationSemantic proximity Read

Enhancer deregulation in cancer and other diseases.Semantic proximity Read

Functional anatomy of distant-acting mammalian enhancers.Semantic proximity Read

Transcriptionally active enhancers in human cancer cells.Semantic proximity Read

Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer.Semantic proximity Read

Integrative Ranking Of Enhancer Networks Facilitates The Discovery Of Epigenetic Markers In CancerSemantic proximity Read

Leveraging Tissue-Specific Enhancer-Target Gene Regulatory Networks Identifies Enhancer Somatic Mutations That Functionally Impact Lung Cancer.Semantic proximity Read

Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers.Semantic proximity Read